SEC Form D private-offering filing

Centile Bioscience Inc.

Name: Centile Bioscience Inc. - new SEC Form D private-offering filing, Bethesda, MD
Published: 2026-04-16

A new SEC Form D private-offering notice from Bethesda, MD, a $4,054,996 filer-stated offering target in Biotech. The source filing is one click away.

Centile Bioscience Inc. site↗ Verified via SEC Form D

Develops CentileOS, a software platform that turns brain imaging data into standardized, population referenced biomarkers for neuroscience research and CNS drug development

Filed 2026-04-16Filed to raise $4,054,996First money in 2026-03-20Raised so far $3,054,996HQ (as filed) Bethesda, MDSector Biotech ✓Stage (inferred) SeedCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified centilebio.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Maryland →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.